Meanwhile, the dysbalance between CRF1 and CRF2 (two CRH receptors) activation and, consequently, alteration of serotoninergic signaling may result in anxiety and depression, associated with hyperactivity of the HPA axis (Kovács et al., 2025). The gene discussed is CRHR2; the disease is depressive disorder.